Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.

MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Abstract Text:

    yasuo amanoYasuo Amano,morimasa takayamaMorimasa Takayama,maki amanoMaki Amano,tatsuo kumazakiTatsuo Kumazaki,

    OBJECTIVE: The objective of our study was to use MRI to show the cardiac morphology and function of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation. CONCLUSION: Black blood T2-weighted and contrast-enhanced fast inversion recovery gradient-echo images displayed ablated septal myocardium until 35 weeks after percutaneous transluminal septal myocardial ablation. Central hypointense areas were observed on MRI in patients until 4 weeks after ablation. Black blood and cine steady-state free precession MRI were used to assess the decreased septal wall thickness and diameter of the left atrium after ablation as well as the reduced motion of the ablated region. MRI may be useful for evaluation of cardiac structural, signal, and functional changes associated with percutaneous transluminal septal myocardial ablation.

    MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Publishing Authors By Initials

    y amanoY Amano,m takayamaM Takayama,m amanoM Amano,t kumazakiT Kumazaki,

    For similar diagnosis: prognosis: treatment outcome research abstracts see: diagnosis: prognosis: treatment outcome research

    PUBMED ID PMID:

    MEDLINE DATE:

    MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: AJR. American journal of roentgenology

    VOLUME: 182

    Page Numbers: 523-7

    Journal Abbreviation:

    ISSN: 0361-803X

    DAY: 15

    MONTH: Feb

    YEAR: 2004

    MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 7708173

    MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Keywords Mesh Terms:

    KEYWORDS: Treatment Outcome

    MESH TERMS: pathology

    Chemical & Substance for Abstract: MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.

    AFFILIATION: Department of Radiology, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-ku, Tokyo 113-8603, Japan.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: AJR Am J Roentgenol

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News